| Report Title | Price | Action |
|---|---|---|
| Addiction (Central Nervous System) - Drugs in Development, 2021
Addiction (Central Nervous System) - Drugs in Development, 2021 Summary Addiction (Central Nervous System) - Drugs in Development, 2021 provides an ...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Mycosis Fungoides (Oncology) - Drugs in Development, 2021
Mycosis Fungoides (Oncology) - Drugs in Development, 2021 Summary Mycosis Fungoides (Oncology) - Drugs in Development, 2021 provides an overview of ...
Published: Apr-2021 | No. of Pages: 65
|
$ 2000 | |
| Adenoviridae Infections (Infectious Disease) - Drugs in Development, 2021
Adenoviridae Infections (Infectious Disease) - Drugs in Development, 2021 Summary Adenoviridae Infections (Infectious Disease) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 55
|
$ 2000 | |
| Cells Expressing CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or CD40LG) - Drugs in Development, 2021
Cells Expressing CD40 Ligand (T Cell Antigen Gp39 or TNF Related Activation Protein or Tumor Necrosis Factor Ligand Superfamily Member 5 or CD154 or C...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Farnesyl Pyrophosphate Synthase (Farnesyl Diphosphate Synthase or (2E,6E) Farnesyl Diphosphate Synthase or Dimethylallyltranstransferase or Geranyltranstransferase or FDPS or EC 2.5.1.10 or EC 2.5.1.1) - Drugs in Development, 2021
Farnesyl Pyrophosphate Synthase (Farnesyl Diphosphate Synthase or (2E,6E) Farnesyl Diphosphate Synthase or Dimethylallyltranstransferase or Geranyltra...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| ADP Ribosylation Factor 6 (ARF6) - Drugs in Development, 2021
ADP Ribosylation Factor 6 (ARF6) - Drugs in Development, 2021 Summary ADP Ribosylation Factor 6 (ARF6) - Drugs in Development, 2021 provides in dept...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) (Respiratory) - Drugs in Development, 2021
Interstitial Lung Diseases (Diffuse Parenchymal Lung Disease) (Respiratory) - Drugs in Development, 2021 Summary Interstitial Lung Diseases (Diffuse...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Streptococcal Pneumonia (Infectious Disease) - Drugs in Development, 2021
Streptococcal Pneumonia (Infectious Disease) - Drugs in Development, 2021 Summary Streptococcal Pneumonia (Infectious Disease) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 140
|
$ 2000 | |
| Myelofibrosis (Hematological Disorders) - Drugs in Development, 2021
Myelofibrosis (Hematological Disorders) - Drugs in Development, 2021 Summary Myelofibrosis (Hematological Disorders) - Drugs in Development, 2021 pr...
Published: Apr-2021 | No. of Pages: 125
|
$ 2000 | |
| Ageing (Other Diseases) - Drugs in Development, 2021
Ageing (Other Diseases) - Drugs in Development, 2021 Summary Ageing (Other Diseases) - Drugs in Development, 2021 provides an overview of the Ageing...
Published: Apr-2021 | No. of Pages: 105
|
$ 2000 | |
| Cells Expressing CD44 Antigen (CDw44 or Epican or Extracellular Matrix Receptor III or GP90 Lymphocyte Homing/Adhesion Receptor or HUTCH I or Heparan Sulfate Proteoglycan or Hermes Antigen or Hyaluronate Receptor or Phagocytic Glycoprotein 1 or CD44) - Drugs in Development, 2021
Cells Expressing CD44 Antigen (CDw44 or Epican or Extracellular Matrix Receptor III or GP90 Lymphocyte Homing/Adhesion Receptor or HUTCH I or Heparan ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| G Protein Coupled Receptor (Seven Transmembrane Domain Receptor or GPCR) - Drugs in Development, 2021
G Protein Coupled Receptor (Seven Transmembrane Domain Receptor or GPCR) - Drugs in Development, 2021 Summary G Protein Coupled Receptor (Seven Tran...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Alpha Adrenergic Receptor (ADRA) - Drugs in Development, 2021
Alpha Adrenergic Receptor (ADRA) - Drugs in Development, 2021 Summary Alpha Adrenergic Receptor (ADRA) - Drugs in Development, 2021 provides in dept...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Tay-Sachs Disease (Genetic Disorders) - Drugs in Development, 2021
Tay-Sachs Disease (Genetic Disorders) - Drugs in Development, 2021 Summary Tay-Sachs Disease (Genetic Disorders) - Drugs in Development, 2021 provid...
Published: Apr-2021 | No. of Pages: 45
|
$ 2000 | |
| Childhood Epilepsy (Central Nervous System) - Drugs in Development, 2021
Childhood Epilepsy (Central Nervous System) - Drugs in Development, 2021 Summary Childhood Epilepsy (Central Nervous System) - Drugs in Development,...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Myotonic Dystrophy (Musculoskeletal) - Drugs in Development, 2021
Myotonic Dystrophy (Musculoskeletal) - Drugs in Development, 2021 Summary Myotonic Dystrophy (Musculoskeletal) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 75
|
$ 2000 | |
| Allergic Asthma (Respiratory) - Drugs in Development, 2021
Allergic Asthma (Respiratory) - Drugs in Development, 2021 Summary Allergic Asthma (Respiratory) - Drugs in Development, 2021 provides an overview o...
Published: Apr-2021 | No. of Pages: 115
|
$ 2000 | |
| Cells Expressing CD70 Antigen (CD27 Ligand or Tumor Necrosis Factor Ligand Superfamily Member 7 or CD70) - Drugs in Development, 2021
Cells Expressing CD70 Antigen (CD27 Ligand or Tumor Necrosis Factor Ligand Superfamily Member 7 or CD70) - Drugs in Development, 2021 Summary Cells ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Gelsolin (AGEL or Actin Depolymerizing Factor or Brevin or GSN) - Drugs in Development, 2021
Gelsolin (AGEL or Actin Depolymerizing Factor or Brevin or GSN) - Drugs in Development, 2021 Summary Gelsolin (AGEL or Actin Depolymerizing Factor o...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) - Drugs in Development, 2021
Aquaporin 4 (Mercurial Insensitive Water Channel or WCH4 or AQP4) - Drugs in Development, 2021 Summary Aquaporin 4 (Mercurial Insensitive Water Chan...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 |